Nurse Practitioner, Family · Rochester, NY
NPI
1093726440
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2410 Ridgeway Ave
Rochester, NY, 14626
Phone (585) 723-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,633
223 services
Medicare patients, 2024
170
Average age 74
Drug cost, 2024
$3.0M
1,515 prescriptions
Company payments, 2025
$565
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Freda B Hannafon was code 99213 (office e&m - established), 152 times for 125 patients. In total Freda B Hannafon billed 223 services in 5 codes, and Medicare paid $8,633.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 152 | 125 | $36.32 | $5,521 |
| 99212 Office E&M - Established | Office | 31 | 27 | $22.29 | $691 |
| 99203 Office E&M - New | Office | 23 | 23 | $47.90 | $1,102 |
By year: 2022 $10K for 234 services; 2023 $12K for 289 services; 2024 $8,633 for 223 services.
Medicare prescription drug claims, 2024
In 2024, the drug Freda B Hannafon prescribed most often to Medicare patients was Prolia (Denosumab), with 552 prescriptions and refills. In total Freda B Hannafon wrote 1,515 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prolia Denosumab | 552 | 3,289 | 346 | $878K |
| Alendronate Sodium Generic | 155 | 424 | 47 | $1,769 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 139 | 139 | 17 | $319K |
| Levothyroxine Sodium Generic | 115 | 289 | 31 | $1,650 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 90 | 266 | 39 | $4,695 |
| Tymlos Abaloparatide | 85 | 145 | 24 | $348K |
| Teriparatide Generic | 81 | 126 | 20 | $280K |
| Risedronate Sodium Dr Risedronate Sodium | 34 | 93 | 11 | $11K |
| Forteo Teriparatide | 30 | 30 | Under 11 | $122K |
| Calcitriol Generic | 26 | 51 | Under 11 | $631 |
| Gabapentin Generic | 22 | 22 | Under 11 | $73.21 |
| Synthroid Levothyroxine Sodium | 22 | 61 | Under 11 | $1,611 |
| Methimazole Generic | 22 | 57 | Under 11 | $162 |
| Strensiq Asfotase Alfa | 20 | 20 | Under 11 | $1.1M |
| Meloxicam Generic | 19 | 22 | Under 11 | $56.57 |
Brand drugs: 987 claims; generic drugs: 425 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Freda B Hannafon $565 ($565 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $394.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.